Early Pharmacokinetic and Clinical Results from a Noncomparative Multicentre Trial of Amphotericin B Encapsulated in a Small Unilamellar Liposome (AmBisome®)
- 1 June 1992
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 4 (3) , 232-238
- https://doi.org/10.1007/bf03258404
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Infectious Complications in Liver TransplantationPublished by American Medical Association (AMA) ,1988
- Ketoconazole in the Prevention of Candidiasis in Patients With CancerArchives of internal medicine (1960), 1987
- Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.Journal of Clinical Oncology, 1987
- Distribution and Activity of Amphotericin B in HumansThe Journal of Infectious Diseases, 1985
- Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary StudyThe Journal of Infectious Diseases, 1985
- Cefmenoxime Efficacy, Safety, and Pharmacokinetics in Critical Care Patients with Nosocomial PneumoniaThe American Journal of Medicine, 1984
- In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin BAntimicrobial Agents and Chemotherapy, 1984
- Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin BThe Journal of Infectious Diseases, 1983
- Fungal Sepsis in Surgical PatientsArchives of Surgery, 1983
- Effects of Sterols on the Therapeutic Efficacy of Liposomal Amphotericin B in Murine CandidiasisCancer Drug Delivery, 1983